Literature DB >> 23909490

Polymorphisms in the ERCC1 and XPF genes and risk of breast cancer in a Chinese population.

Zecheng Yang1, Xuedong Fang, Xinhong Pei, Huixiang Li.   

Abstract

Inherited functional single-nucleotide polymorphisms (SNPs) in DNA repair genes may influence the capability of DNA repair and contribute to the risk of breast cancer. We therefore performed a case-control study to investigate the association of three in excision repair cross-complimentary group 1 (ERCC1) and three in xeroderma pigmentosum complementation group F (XPF) with the risk of breast cancer. Genotyping of ERCC1 (rs2298881, rs3212986, and rs11615) and XPF (rs2276465, rs6498486, and rs2276466) was performed in a 384-well plate format on the MassARRAY(®) platform. Odds ratios and their corresponding 95% confidence intervals were used to assess the effect of each SNP on breast cancer risk. The ERCC1 rs11615 variant A/A genotype was associated with increased breast cancer risk in codominant, dominant, and recessive models, and XPF rs6498486 variant C/C genotype carriers have a significantly increased breast cancer risk in codominant, dominant, and recessive models. Individuals with both the ERCC1 rs11615 A allele and XPF rs6498486 C allele had a heavy increased risk of breast cancer compared to double wild-type homozygotes. The present study shows that the ERCC1 rs11615 and XPF rs6498486 polymorphisms are associated with breast cancer risk in a Chinese population. Further large-scale studies are required to elucidate whether these ERCC1 and XPF SNPs interact with environmental factors in the development of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23909490      PMCID: PMC3761393          DOI: 10.1089/gtmb.2013.0122

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  32 in total

Review 1.  The base excision repair: mechanisms and its relevance for cancer susceptibility.

Authors:  P Fortini; B Pascucci; E Parlanti; M D'Errico; V Simonelli; E Dogliotti
Journal:  Biochimie       Date:  2003-11       Impact factor: 4.079

2.  A specific diplotype defined by PPP1R13L rs1970764, CD3EAP rs967591 and ERCC1 rs11615 and lung cancer risk in a Chinese population.

Authors:  Jiaoyang Yin; Ulla Vogel; Yegang Ma; Huiwen Wang; Chunhong Wang; Duohong Liang; Li Yue; Jian Ma; Xinxin Li
Journal:  Lung Cancer       Date:  2012-02-14       Impact factor: 5.705

Review 3.  Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy.

Authors:  E Reed
Journal:  Cancer Treat Rev       Date:  1998-10       Impact factor: 12.111

Review 4.  How nucleotide excision repair protects against cancer.

Authors:  E C Friedberg
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

5.  Conserved residues of human XPG protein important for nuclease activity and function in nucleotide excision repair.

Authors:  A Constantinou; D Gunz; E Evans; P Lalle; P A Bates; R D Wood; S G Clarkson
Journal:  J Biol Chem       Date:  1999-02-26       Impact factor: 5.157

6.  Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer.

Authors:  D Isla; C Sarries; R Rosell; G Alonso; M Domine; M Taron; G Lopez-Vivanco; C Camps; M Botia; L Nuñez; M Sanchez-Ronco; J J Sanchez; M Lopez-Brea; I Barneto; A Paredes; B Medina; A Artal; P Lianes
Journal:  Ann Oncol       Date:  2004-08       Impact factor: 32.976

Review 7.  Environmental causes of esophageal cancer.

Authors:  Farin Kamangar; Wong-Ho Chow; Christian C Abnet; Sanford M Dawsey
Journal:  Gastroenterol Clin North Am       Date:  2009-03       Impact factor: 3.806

Review 8.  Impact of aging on the biology of breast cancer.

Authors:  Christopher C Benz
Journal:  Crit Rev Oncol Hematol       Date:  2007-10-18       Impact factor: 6.312

9.  Polymorphisms in ERCC1 and XPF genes and risk of gastric cancer in an eastern Chinese population.

Authors:  Jing He; Yu Xu; Li-Xin Qiu; Jin Li; Xiao-Yan Zhou; Meng-Hong Sun; Jiu-Cun Wang; Ya-Jun Yang; Li Jin; Qing-Yi Wei; Yanong Wang
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

10.  A distinct ERCC1 haplotype is associated with mRNA expression levels in prostate cancer patients.

Authors:  Andreas Woelfelschneider; Odilia Popanda; Carmen Lilla; Jakob Linseisen; Claudia Mayer; Oktay Celebi; Jürgen Debus; Helmut Bartsch; Jenny Chang-Claude; Peter Schmezer
Journal:  Carcinogenesis       Date:  2008-03-10       Impact factor: 4.944

View more
  18 in total

1.  Polymorphisms in ERCC1 gene could predict clinical outcome of platinum-based chemotherapy for non-small cell lung cancer patients.

Authors:  Xin Zhao; Zhiqiang Zhang; Yan Yuan; Xiaomei Yuan
Journal:  Tumour Biol       Date:  2014-05-24

2.  The C8092A polymorphism in the ERCC1 gene and breast carcinoma risk: a meta-analysis of case-control studies.

Authors:  Xu-Guang Guo; Qian Wang; Yong Xia; Lei Zheng
Journal:  Int J Clin Exp Med       Date:  2015-03-15

3.  Association of single nucleotide polymorphisms of nucleotide excision repair genes with laryngeal cancer risk and interaction with cigarette smoking and alcohol drinking.

Authors:  Xiaoyu Li; Jing Xu; Xinxin Yang; Yungang Wu; Baohua Cheng; Dongfeng Chen; Bo Bai
Journal:  Tumour Biol       Date:  2014-02-22

4.  Association of single-nucleotide polymorphisms in ERCC1 and ERCC2 with glioma risk.

Authors:  Lei Hui; Shuangzhu Yue; Guojun Gao; Haigang Chang; Xiangsheng Li
Journal:  Tumour Biol       Date:  2014-05-01

5.  Association study of germline variants in CCNB1 and CDK1 with breast cancer susceptibility, progression, and survival among Chinese Han women.

Authors:  Yan Li; Yi-Lin Chen; Yun-Tao Xie; Li-Yuan Zheng; Ji-Yuan Han; Hui Wang; Xin-Xia Tian; Wei-Gang Fang
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

6.  Influence of ERCC1 and ERCC4 polymorphisms on response to prognosis in gastric cancer treated with FOLFOX-based chemotherapy.

Authors:  Zheng-mao Lu; Tian-hang Luo; Ming-ming Nie; Guo-en Fang; Li-ye Ma; Xu-chao Xue; Guo Wei; Chong-we Ke; Jian-wei Bi
Journal:  Tumour Biol       Date:  2013-12-08

7.  Role of ERCC1 variants in response to chemotherapy and clinical outcome of advanced non-small cell lung cancer.

Authors:  Shao-jun Huang; Yu-fei Wang; Zhi-yong Jin; Jia-yang Sun; Zhan-lin Guo
Journal:  Tumour Biol       Date:  2013-12-27

8.  Analysis of ERCC1 and ERCC2 gene variants in osteosarcoma, colorectal and breast cancer.

Authors:  Benjamín Gómez-Díaz; María DE LA Luz Ayala-Madrigal; Melva Gutiérrez-Angulo; Aura Erazo Valle-Solis; Luis Miguel Linares-González; Roberto González-Guzmán; David Cruz-Guillén; Ana Lilia Cedeño-Garcidueñas; Patricia Canto; Luz Berenice López-Hernández
Journal:  Oncol Lett       Date:  2015-01-26       Impact factor: 2.967

9.  Association between ERCC1 Polymorphism and the Risk and Clinicopathological Features of Breast Cancer in Thai Women in the Lower Northeastern Region

Authors:  Malinee Pongsavee; Kamol Wisuwan; Danai Tiwawech
Journal:  Asian Pac J Cancer Prev       Date:  2017-11-26

10.  Nucleotide excision repair pathway gene polymorphisms are linked to breast cancer risk in a Chinese population.

Authors:  Bang-Shun He; Tao Xu; Yu-Qin Pan; Han-Jin Wang; William C Cho; Kang Lin; Hui-Ling Sun; Tian-Yi Gao; Shu-Kui Wang
Journal:  Oncotarget       Date:  2016-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.